Schaeffer's Top Stock Picks for '25

Dow Jones Industrial Average Pushes For Another Weekly Win

Don't Blame the VIX

Oct 16, 2015 at 12:09 PM
facebook X logo linkedin


The Dow Jones Industrial Average (DJIA) is higher at midday, as traders weigh the latest round of earnings and economic data. Industrial production and job openings both edged lower for the month -- supporting the case for a delayed rate hike from the Fed -- while consumer sentiment turned higher. Also stoking the bullish flames is stimulus chatter out of Asia and a strong quarterly showing from blue chip General Electric Company (NYSE:GE), which just hit a seven-year high. As it stands now, the Dow, S&P 500 Index (SPX), ​and ​Nasdaq Composite (COMP) ​are all on pace for a third straight weekly win. 

Continue reading for more on today's market -- and don't miss:

 

  • As volatility products come under fire, Schaeffer's contributor Adam Warner says don't blame the VIX for troubles in the stock market. 
  • Does this fast-food chain's new board addition point to a spin-off in the works? 
  • Plus ... Checking in on the CBOE Volatility Index (VIX), the SPDR S&P 500 ETF Trust SPY, and other noteworthy stats at midday.




151016MMC1




Among the stocks with notable put activity is Spirit Airlines Incorporated (NASDAQ:SAVE), after the company warned of a substantial drop in unit revenue for the fourth quarter. The shares earlier touched an annual low of $42.77, and were last seen down 13.6% at $43.24. As such, puts on the airliner are crossing at seven times the average midday pace, with the November 45 put coming in as the most popular contract.

Among the Big Board gainers is diagnostics firm Opko Health Inc. (NYSE:OPK), following a bullish note from J.P. Morgan Securities. The brokerage firm initiated coverage with an "overweight" rating and $14 price target, sending the shares 2.9% higher to $9.55. However, the security remains well below its record high of $19.20, hit in early June. 

151016OPK

Among the biggest losers on the Nasdaq is Zafgen Inc (NASDAQ:ZFGN). The biotech has surrendered more than one-third of its value to trade at $13.95, after the U.S. Food and Drug Administration (FDA) put a partial hold on drug trials for its obesity drug in response to a patient's death. 

The CBOE Volatility Index (VIX) is off 0.4 point, or 2.4%, on pace for its third straight weekly drop. 

Today's put/call volume ratio on the SPDR S&P 500 ETF Trust (SPY) is 1.61, with puts outnumbering calls. At last check, SPY was up 0.4 point, or 0.2%, at $202.77. 

 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter